Foundation Medicine IPO Research Information

Foundation Medicine IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Foundation Medicine, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Foundation Medicine	FMI - NASDAQ	$14.00-$16.00	$18.00	$31.50	5.89 million	9/25/2013
Underwriter(s): Goldman Sachs, J.P. Morgan
Co-Manager(s): Leerink Swann, Sanford Bernstein
Industry: Health Care
Filing(s): Filed 2013-07-29

Foundation Medicine Quote & Chart - Click for current quote - FMI

About Foundation Medicine (adapted from Foundation Medicine prospectus):
They are a commercial-stage company focused on fundamentally changing the way patients with cancer are treated.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "FMI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.